Drug General Information
Drug ID
D0R1SV
Former ID
DCL000400
Drug Name
GSK1014802
Drug Type
Small molecular drug
Indication Bipolar disorder [ICD9: 296.0, 296.1, 296.4, 296.5, 296.6, 296.7, 296.8, 300; ICD10:F31, F40-F42] Phase 2 [548689]
Company
GSK
Structure
Download
2D MOL

3D MOL

Formula
C18H12Cl2N2O3
Canonical SMILES
C1=CC=C(C=C1)NC(=O)C=CC2=C(NC3=CC(=CC(=C32)Cl)Cl)C(=O)O
InChI
1S/C18H12Cl2N2O3/c19-10-8-13(20)16-12(17(18(24)25)22-14(16)9-10)6-7-15(23)21-11-4-2-1-3-5-11/h1-9,22H,(H,21,23)(H,24,25)/b7-6+
InChIKey
WZBNEZWCNKUOSM-VOTSOKGWSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Sodium channel Target Info Blocker [550963]
KEGG Pathway Dopaminergic synapse
Reactome Interaction between L1 and Ankyrins
References
Ref 548689Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027679)
Ref 550963Clinical pipeline report, company report or official report of GlaxoSmithKline (2009).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.